Benitec Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 469.1%.

Top 21 shareholders own 49.14% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
18.1%	Suvretta Capital Management, LLC	1,691,290	US$11.8m	728%	0.51%
8.98%	HBM Partners Ltd.	841,395	US$5.9m	0%	0.63%
7.97%	Steven Oliveira	746,324	US$5.2m	660%	no data
6.28%	Franklin Resources, Inc.	588,310	US$4.1m	0.01%	no data
2.61%	Janus Henderson Group plc	244,491	US$1.7m	35.5%	no data
2.02%	Adage Capital Management, L.P.	189,188	US$1.3m	0%	no data
0.92%	Heights Capital Management, Inc.	86,447	US$604.3k	0%	0.26%
0.56%	J. Buchi	52,097	US$364.2k	0%	no data
0.51%	Simplify Asset Management Inc.	47,407	US$331.4k	0%	0.03%
0.48%	IRA Financial Group LLC/IRA Financial Trust Company	44,911	US$313.9k	0%	no data
0.28%	Megan Boston	25,927	US$181.2k	0%	no data
0.18%	The Vanguard Group, Inc.	16,701	US$116.7k	0%	no data
0.13%	Morgan Stanley, Investment Banking and Brokerage Investments	11,800	US$82.5k	131%	no data
0.11%	Geode Capital Management, LLC	10,024	US$70.1k	0%	no data
0.038%	GAMMA Investing LLC	3,554	US$24.8k	955%	0.01%
0.019%	Tower Research Capital LLC	1,745	US$12.2k	-30.1%	no data
0.0055%	UBS Asset Management AG	512	US$3.6k	-17.7%	no data
0.0032%	Peter Francis	297	US$2.1k	0%	no data
0.002%	Rhumbline Advisers Ltd Partnership	186	US$1.3k	0%	no data
0.00095%	Group One Trading LP, Asset Management Arm	89	US$622.0	0%	no data
0.00018%	Wells Fargo & Company, Private Banking and Investment Banking Arm	17	US$117.9	0%	no data